(Q49055779)

18 February 2018

title

Brain positron emission tomography in splenectomized adults with β-thalassemia intermedia: uncovering yet another covert abnormality. (English)

1 reference

18 February 2018

positron emission tomography

main subject

1 reference

1

1 reference

18 February 2018

Ali Taher

8

1 reference

18 February 2018

author name string

Wassim Nasreddine

2

1 reference

18 February 2018

Ahmad Beydoun

3

1 reference

18 February 2018

Roula Hourani

4

1 reference

18 February 2018

Ahmed Hankir

5

1 reference

18 February 2018

Suzanne Koussa

6

1 reference

18 February 2018

Mohamad Haidar

7

1 reference

18 February 2018

publication date

13 July 2011

1 reference

18 February 2018

published in

Annals of Hematology

1 reference

18 February 2018

volume

91

1 reference

18 February 2018

issue

2

1 reference

18 February 2018

page(s)

235-241

1 reference

18 February 2018

Optimal management of β thalassaemia intermedia.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Redefining thalassemia as a hypercoagulable state

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Splenectomy and thrombosis: the case of thalassemia intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/beta-thalassaemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Absence of cardiac siderosis despite hepatic iron overload in Italian patients with thalassemia intermedia: an MRI T2* study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Iron chelation and neuroprotection in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Sickle cell disease and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Brain glucose metabolism in neurologically normal patients with sickle cell disease. Regional alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Measurement of regional cerebral blood flow, blood volume and oxygen metabolism in patients with sickle cell disease using positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Role of positron emission tomography in determining the extent of CNS ischemia in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Local cerebral glucose metabolism in patients with long-term behavioral and cognitive deficits following mild traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Pathophysiology and treatment of stroke in sickle-cell disease: present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Neuropsychologic performance in school-aged children with sickle cell disease: a report from the Cooperative Study of Sickle Cell Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Abnormal cranial magnetic resonance imaging scans in sickle-cell disease. Neurological correlates and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Neuroimaging in assessment of risk of stroke in children with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00277-011-1291-3

10.1007/S00277-011-1291-3

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

21750926

1 reference

18 February 2018